Search results
Showing 76 to 90 of 166 results for atrial fibrillation
Reversal of the anticoagulant effect of dabigatran: idarucizumab (ESNM73)
Summary of the evidence on idarucizumab for reversing the anticoagulant effect of dabigtatran to inform local NHS planning and decision-making
This indicator covers the percentage of patients with moderate or severe frailty and/or multimorbidity who have received a medication review in the last 12 months which is structured, has considered the use of a recognised tool and taken place as a shared discussion. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM186
Supporting the health and care system in improving productivity
Recovering core services and improving productivity is an immediate priority for the NHS. To help, we’ve put all our relevant guidance and recommendations supporting this work in one place.
VERO and NObreath April 2014 DG12 Review decision DG14 Atrial fibrillation and heart valve disease: self-monitoring coagulation status...
yield of the BioMonitor 2‑AF and Confirm Rx (or later devices) for atrial fibrillation when used in people who have had a cryptogenic...
Multiple long-term conditions: multimorbidity register (IND205)
This indicator covers the practice can produce a register of people with multimorbidity who would benefit from a tailored approach to care. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes. This indicator was previously published as NM184
Evidence-based recommendations on The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters.
NICE has developed a medtech innovation briefing (MIB) on microINR for anticoagulation therapy .
This guideline covers identifying and treating primary hypertension (high blood pressure) in people aged 18 and over, including people with type 2 diabetes. It aims to reduce the risk of cardiovascular problems such as heart attacks and strokes by helping healthcare professionals to diagnose hypertension accurately and treat it effectively.
non‑rheumatic/calcific mitral stenosis, in both sinus rhythm and atrial fibrillation? Any explanatory notes(if applicable) Source...
Atrial fibrillation: management (CG180)
Wigan Borough CCG has employed a team of pharmacists and pharmacy technicians to work with GP practices, residential and nursing homes to carry out structured medication reviews for care homes
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using
Evidence-based recommendations on thoracoscopically assisted mitral valve surgery. This involves repairing a defective valve through one or more small incisions between the ribs rather than one large incision through the breastbone (sternum).
View recommendations for IPG245Show all sections
Sections for IPG245
Optimising Medication in patients with Chronic Heart Failure
blood pressure management, lipid management and anticoagulation in atrial fibrillation. Reviewed whether the relevant patient monitoring...